Assessment of renal functional reserve by dynamic renal function testing

Area of Science:

• Nephrology
• Pharmacokinetics
• Renal Physiology

Background:

• Traditional methods using clearance markers like inulin assess glomerular filtration rate (GFR), renal blood flow, and renal vascular resistance.
• Previous studies on renal functional reserve post-protein load or amino acid infusion reported inconsistent findings, with some showing blunted GFR increases and others decreases.
• In hypertensive patients with hyperfiltration, GFR changes and increased intraglomerular pressure after ACE inhibitors were not consistently linked to albumin excretion or expected dynamic GFR responses.

Purpose of the Study:

• To address the inconsistencies in assessing dynamic changes in renal function.
• To propose a more adequate method for studying dynamic clearance changes within clinically feasible timeframes.
• To evaluate the efficacy of therapeutic regimens in patients with hyperfiltering kidneys using a novel approach.

Main Methods:

• Critique of traditional clinical methods for assessing acutely provoked changes in renal function.
• Proposal and application of a two-compartment pharmacokinetic model for studying dynamic clearance changes.
• Evaluation of renal function in patients during washout periods and after long-term drug treatment.

Main Results:

• Traditional methods for assessing acute changes in renal function are deemed inappropriate due to inconsistent results.
• The two-compartment pharmacokinetic model provides a more adequate approach for studying dynamic clearance changes.
• This model allows for the assessment of therapeutic regimen efficacy, particularly in hyperfiltering kidneys.

Conclusions:

• The traditional clinical assessment of acute changes in renal function, especially after protein load, is inadequate.
• A two-compartment pharmacokinetic model is a more suitable method for evaluating dynamic renal clearance changes.
• This pharmacokinetic approach aids in assessing therapeutic efficacy in patients with altered renal function, including hyperfiltration.